5 Best Gene Editing Stocks To Buy
Graphite Bio, Inc. (NASDAQ:GRPH) is a clinical-stage gene editing company based in San Francisco, California. It develops therapies for life-threatening diseases in the United States.
Intellia Therapeutics Inc. (NTLA)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
Cathie Wood is Buying These 10 Stocks in September
In this article, we discuss 10 stocks that Cathie Wood is buying in September.
Top 12 From Cathie Wood's Q2 Portfolio
In this article, we will be taking a look at the top 12 from Cathie Wood's Q2 portfolio.
Cathie Wood Dumped These 3 Stocks in July
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a Massachusetts-based genome editing company that develops novel genomic medicines using CRISPR/Cas9 technology for the treatment of ocular diseases.
Cathie Wood is Not Letting Go of These 5 Stocks Despite Losses
In this article, we discuss 5 stocks that Cathie Wood is not letting go of despite losses.
Cathie Wood's Fund Starts to Rebound: 10 Stocks to Watch
In this article, we discuss 10 stocks to watch as Cathie Wood's fund starts to rebound.
12 Best ARK Stocks To Buy Now
In this article, we discuss the 12 best ARK stocks to buy now.
5 Best Buy-the-Dip Growth Stocks to Buy Now
Tesla, Inc. (NASDAQ:TSLA), the American EV giant, is down over 37% year-to-date as of May 27.
10 Biggest Losers in Cathie Wood's Latest Portfolio
In this article, we discuss the 10 biggest losers in Cathie Wood's latest portfolio.
Cathie Wood's 10 Stock Picks for the Next 5 Years
In this article, we discuss Cathie Wood's 10 stock picks for the next 5 years.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
